ELUTIA INC.

Develops drug-eluting biologics to reduce complications from medical implants.

ELUT | US

Overview

Corporate Details

ISIN(s):: US05479K1060
LEI:
Country:: United States of America
Address:: 12510 PROSPERITY DRIVE, 20904 SILVER SPRING
Website:: https://elutia.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Elutia Inc. is a commercial-stage company that develops and commercializes drug-eluting biologic products to improve compatibility between medical devices and patients. The company's proprietary drug-eluting biomaterial platforms combine natural biologic materials with extended-release antibiotics to address post-surgical complications from implant failures. Its key offerings include CanGaroo, an acellular device envelope for implantable electronics like pacemakers and neurostimulators, and SimpliDerm, a human acellular dermal matrix for soft tissue reconstruction. These products are designed to mitigate fibrotic responses, ensure implant stability, and support wound healing. Formerly known as Aziyo Biologics, the company rebranded to Elutia to reflect its strategic focus on drug-eluting biomatrices.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ELUTIA INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ELUTIA INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for ELUTIA INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
PTC THERAPEUTICS, INC. Develops and commercializes pioneering medicines for patients with rare diseases.	United States of America	PTCT
Pulmatrix, Inc. Develops inhaled therapies for respiratory and CNS disorders using its iSPERSE™ technology.	United States of America	PULM
PUMA BIOTECHNOLOGY, INC. Develops and commercializes innovative cancer therapeutics, with an approved drug and a clinical pipeline.	United States of America	PBYI
Pure Biologics S.A. Develops novel antibody & aptamer drugs for immuno-oncology and autoimmune diseases.	Poland	PUR
PureTech Health plc A clinical-stage biotherapeutics firm developing new medicines for devastating diseases.	United States of America	PRTC
PURPLE BIOTECH LTD. Develops first-in-class therapies targeting tumor immune evasion and drug resistance in cancer.	United States of America	PPBT
Pyxis Oncology, Inc. Developing next-gen ADC and Immuno-Oncology therapeutics for difficult-to-treat cancers.	United States of America	PYXS
PZ Cormay S.A. Manufactures and distributes IVD reagents and analyzers for human and veterinary medicine.	Poland	CRM
Q32 Bio Inc. Clinical-stage biotech developing biologic therapies for autoimmune and inflammatory diseases.	United States of America	QTTB
Quantum Biopharma Ltd. Develops therapies for brain disorders and a functional beverage for post-alcohol wellness.	United States of America	QNTM